DBD (DBD) Stock Analysis
Verdict: HOLD
Aggressive deleveraging and software pivot offer significant valuation re-rating, provided the post-earnings technical breakdown stabilizes.
Investment score: 64/100
Diebold Nixdorf is undervalued relative to its FCF generation and projected 2027 earnings, despite recent technical weakness.
Peers
| Peer | P/E | P/B | P/S | EV/EBITDA | ROIC % | Net margin % |
|---|---|---|---|---|---|---|
| P | 113.49 | 17.47 | 6.52 | 60.77 | — | 0.06 |
| HPQ | 9.95 | -174.60 | 0.43 | 7.88 | — | 0.04 |
| SMCI | 13.59 | 2.24 | 0.55 | 13.51 | — | 0.04 |
| IONQ | 404.89 | 2.63 | 72.69 | 33.49 | — | 1.48 |
| GPGI | -3.94 | 0.54 | 0.00 | -8.39 | — | 0.00 |